RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 96 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $891,000 | -35.2% | 374,383 | -0.2% | 0.00% | -50.0% |
Q3 2016 | $1,376,000 | +78.0% | 375,016 | +8.2% | 0.00% | +100.0% |
Q2 2016 | $773,000 | +17.5% | 346,722 | +9.5% | 0.00% | 0.0% |
Q1 2016 | $658,000 | -32.2% | 316,511 | -1.1% | 0.00% | 0.0% |
Q4 2015 | $970,000 | +23.9% | 320,112 | +1.0% | 0.00% | 0.0% |
Q3 2015 | $783,000 | -24.6% | 316,909 | -2.1% | 0.00% | 0.0% |
Q2 2015 | $1,039,000 | +0.8% | 323,610 | +12.1% | 0.00% | 0.0% |
Q1 2015 | $1,031,000 | +56.4% | 288,736 | -0.5% | 0.00% | 0.0% |
Q4 2014 | $659,000 | -5.3% | 290,262 | -19.1% | 0.00% | 0.0% |
Q3 2014 | $696,000 | -47.0% | 358,627 | -0.8% | 0.00% | -50.0% |
Q2 2014 | $1,312,000 | +13.8% | 361,558 | +21.7% | 0.00% | 0.0% |
Q1 2014 | $1,153,000 | +35.6% | 297,076 | -0.4% | 0.00% | +100.0% |
Q4 2013 | $850,000 | -21.9% | 298,344 | -1.9% | 0.00% | -50.0% |
Q3 2013 | $1,089,000 | +7.9% | 304,203 | +0.7% | 0.00% | 0.0% |
Q2 2013 | $1,009,000 | – | 301,995 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 1,020,719 | $3,746,000 | 2.58% |
Boxer Capital, LLC | 1,351,137 | $4,959,000 | 2.22% |
Palo Alto Investors LP | 5,186,088 | $19,033,000 | 1.11% |
DAFNA Capital Management LLC | 340,000 | $1,248,000 | 0.87% |
SENZAR ASSET MANAGEMENT, LLC | 907,203 | $3,329,435,000 | 0.86% |
Rhenman & Partners Asset Management AB | 1,400,000 | $5,138,000,000 | 0.82% |
NEA Management Company, LLC | 3,243,150 | $11,902,000 | 0.53% |
Cormorant Asset Management, LP | 1,155,600 | $4,241,000 | 0.47% |
Ghost Tree Capital, LLC | 700,000 | $2,569,000 | 0.42% |
Rock Springs Capital Management LP | 1,810,000 | $6,643,000 | 0.42% |